Chapter 1.Research Framework

1.1.Research Objective

1.2.Product Overview

1.3.Market Segmentation

Chapter 2.Research Methodology

2.1.Qualitative Research

2.1.1.Primary & Secondary Sources

2.2.Quantitative Research

2.2.1.Primary & Secondary Sources

2.3.Breakdown of Primary Research Respondents, By Region

2.4.Assumption for the Study

2.5.Market Size Estimation

2.6.Data Triangulation

Chapter 3.Executive Summary: Global Lateral Flow Assay Market

Chapter 4.Global Lateral Flow Assay Market Overview

4.1.Industry Value Chain Analysis

4.1.1.Material Provider

4.1.2.Manufacturer

4.1.3.Service Provider

4.1.4.End User

4.2.Industry Outlook

4.2.1.Various Applications of Point of Care Diagnostic Devices

4.3.PESTLE Analysis

4.4.Porter's Five Forces Analysis

4.4.1.Bargaining Power of Suppliers

4.4.2.Bargaining Power of Buyers

4.4.3.Threat of Substitutes

4.4.4.Threat of New Entrants

4.4.5.Degree of Competition

4.5.Market Dynamics and Trends

4.5.1.Growth Drivers

4.5.2.Restraints

4.5.3.Challenges

4.5.4.Key Trends

4.6.Covid-19 Impact Assessment on Market Growth Trend

4.7.Market Growth and Outlook

4.7.1.Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030

4.7.2.Price Trend Analysis, by product

4.8.Competition Dashboard

4.8.1.Market Concentration Rate

4.8.2.Company Market Share Analysis (Value %), 2020

4.8.3.Competitor Mapping

Chapter 5.Lateral Flow Assay Market Analysis, By Product & Services

5.1.Key Insights

5.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

5.2.1.Readers

5.2.1.1.Bench-top Readers

5.2.1.2.Hand-held Readers

5.2.2.LFA Kits

5.2.2.1.Test Strips

5.2.2.2.Dipsticks

5.2.2.3.Cassettes

5.2.2.4.Lancets

Chapter 6.Lateral Flow Assay Market Analysis, By Indications

6.1.Key Insights

6.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

6.2.1.Infectious Diseases

6.2.1.1.Mosquito-borne Diseases

6.2.1.2.Streptococcus Infections

6.2.1.3.Sexually Transmitted Diseases

6.2.1.4.Hepatitis

6.2.1.5.Tuberculosis

6.2.1.6.Asthma

6.2.1.7.Pneumonia

6.2.1.8.Sepsis

6.2.1.9.Gastrointestinal Infections

6.2.1.10.Others

6.2.2.Pregnancy Test

6.2.3.Drug of Abuse Testing

Chapter 7.Lateral Flow Assay Market Analysis, By Technique

7.1.Key Insights

7.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

7.2.1.Sandwich Assays

7.2.2.Competitive Assays

7.2.3.Multiplex Detection Assays

Chapter 8.Lateral Flow Assay Market Analysis, By End User

8.1.Key Insights

8.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

8.2.1.Hospitals & Clinics

8.2.2.Diagnostics Laboratories

8.2.3.Home Care Settings

8.2.4.Pharmaceuticals & Biotechnology Companies

8.2.5.Other

Chapter 9.Lateral Flow Assay Market Analysis, By Distribution Channel

9.1.Key Insights

9.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

9.2.1.Hospital Pharmacies

9.2.2.Retail Pharmacies

9.2.3.Supermarkets/Hypermarkets

9.2.4.e-Commerce

Chapter 10.Lateral Flow Assay Market Analysis, By Region

10.1.Key Insights

10.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

10.2.1.North America

10.2.1.1.The U.S.

10.2.1.2.Canada

10.2.1.3.Mexico

10.2.2.Europe

10.2.2.1.Western Europe

10.2.2.1.1.The UK

10.2.2.1.2.Germany

10.2.2.1.3.France

10.2.2.1.4.Italy

10.2.2.1.5.Spain

10.2.2.1.6.Rest of Western Europe

10.2.2.2.Eastern Europe

10.2.2.2.1.Poland

10.2.2.2.2.Russia

10.2.2.2.3.Rest of Eastern Europe

10.2.3.Asia Pacific

10.2.3.1.China

10.2.3.2.India

10.2.3.3.Japan

10.2.3.4.South Korea

10.2.3.5.Australia & New Zealand

10.2.3.6.ASEAN

10.2.3.7.Rest of Asia Pacific

10.2.4.Middle East & Africa

10.2.4.1.UAE

10.2.4.2.Saudi Arabia

10.2.4.3.South Africa

10.2.4.4.Rest of MEA

10.2.5.South America

10.2.5.1.Argentina

10.2.5.2.Brazil

10.2.5.3.Rest of South America

Chapter 11.North America Lateral Flow Assay Market Analysis

11.1.Key Insights

11.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

11.2.1.By Product & Services

11.2.2.By Indication

11.2.3.By Technique

11.2.4.By End User

11.2.5.By Distribution Channel

11.2.6.By Country

Chapter 12.Europe Lateral Flow Assay Market Analysis

12.1.Key Insights

12.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

12.2.1.By Product & Services

12.2.2.By Indication

12.2.3.By Technique

12.2.4.By End User

12.2.5.By Distribution Channel

12.2.6.By Country

Chapter 13.Asia Pacific Lateral Flow Assay Market Analysis

13.1.Key Insights

13.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

13.2.1.By Product & Services

13.2.2.By Indication

13.2.3.By Technique

13.2.4.By End User

13.2.5.By Distribution Channel

13.2.6.By Country

Chapter 14.Middle East and Africa Lateral Flow Assay Market Analysis

14.1.Key Insights

14.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

14.2.1.By Product & Services

14.2.2.By Indication

14.2.3.By Technique

14.2.4.By End User

14.2.5.By Distribution Channel

14.2.6.By Country

Chapter 15.South America Lateral Flow Assay Market Analysis

15.1.Key Insights

15.2.Market Size and Forecast, 2017 - 2030 (US$ Mn)

15.2.1.By Product & Services

15.2.2.By Indication

15.2.3.By Technique

15.2.4.By End User

15.2.5.By Distribution Channel

15.2.6.By Country

Chapter 16.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

16.1.Abbott Laboratories

16.2.bioMerieux S.A

16.3.Bio-Rad Laboratories Inc.

16.4.Danaher Corporation

16.5.F. Hoffmann-La Roche Ltd.

16.6.Hologic Inc.

16.7.Merck KGaA

16.8.PerkinElmer Inc.

16.9.Qiagen N.V.

16.10.Quidel Corporation

16.11.Siemens Healthineers

16.12.Thermo Fisher Scientific, Inc.,

16.13.Other Prominent Players